"2018 was an exciting and productive year for kidney cancer research," write Amr A. Elbakry, MBBCh, MSc, and Ketan K. Badani, MD.
Ketan K. Badani, MD
Advertisement
Articles by Ketan K. Badani, MD
Advertisement
Latest Updated Articles
- RCC 2018: Top advances in treatment of localized, advanced disease
Published: January 18th 2019 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC
2
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
3
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
4
Modern frameworks for treating high-risk non–muscle invasive bladder cancer
5
